Meet our senior team
Nawab Qizilbash, MD MSc DPhil
Chief Medical Officer & CEO
Dr Qizilbash is Chief Medical Officer and CEO of OXON Epidemiology, where he provides senior medical and epidemiological leadership across the design, conduct and interpretation of real-world evidence studies. As a Senior Clinical Epidemiologist, he brings together extensive expertise in clinical medicine, epidemiology, meta-analysis and evidence-based medicine, offering clients a distinctive combination of scientific rigor, strategic insight and practical clinical perspective.
He is also Honorary Associate Professor at the London School of Hygiene & Tropical Medicine, Honorary Consultant Geriatrician in Madrid, and a member of Green Templeton College, University of Oxford. These roles reflect the strong academic and clinical foundations that continue to inform his work at OXON.
His previous background spans senior leadership roles in epidemiology within the pharmaceutical industry, together with extensive academic and clinical experience in internal medicine and geriatrics. He trained and worked at internationally recognised institutions including the University of Oxford and the London School of Hygiene & Tropical Medicine, and collaborated with leading figures such as Professor Sir Richard Peto and Professor Sir John Grimley Evans. This combination of industry, academic and clinical experience enables him to bring both methodological depth and applied judgement to OXON’s projects.
Dr Qizilbash has co-authored multiple high-impact publications, including 8 in The Lancet, 1 in JAMA and 3 in BMJ, covering topics such as epidemiology, pragmatic trials and meta-analysis. He was also the founding editor of the Cochrane Dementia Group and chief editor of the textbook Evidence-Based Dementia Practice.
Among CROs in Europe, he offers clients a rare combination of high-level epidemiological and clinical expertise across a wide range of therapeutic areas.
Lorenzo Domínguez, MD MPH
Director of Quality Assurance
Lorenzo is a medical doctor and public health specialist with more than 30 years of experience in epidemiology, pharmacoepidemiology, pharmacovigilance, and quality assurance. At OXON Epidemiology, he serves as Director of the Quality Department, leading quality strategy, regulatory compliance, and continuous improvement across the organisation.
He previously held the role of Director of Operations at OXON, where he was responsible for operational strategy, study oversight, team leadership, and process optimisation. Before joining OXON, he held senior roles at AstraZeneca and SGS Life Science Services. He also has academic experience as an Associate Professor of Epidemiology and Public Health and has contributed to multiple scientific publications and conference communications.
Ignacio Méndez, VMD MPH
Director of Data Analytics & HEOR
Ignacio Méndez is a clinical veterinary with a Master’s degree in Public Health & Epidemiology and more than 25 years of experience in epidemiology, biostatistics, health economics, patient-reported outcomes, and related analytical methodologies. As Director of Data Analytics & HEOR at OXON Epidemiology, he leads the methodological and analytical components of observational studies, secondary database studies, health economic evaluations, and decision models. He has particular expertise in the observational study design and statistical analysis; safety data; design, validation, and analysis of patient-reported outcomes; health services research and health economic measures, as well as in systematic reviews, meta-analyses.
Before joining OXON, he developed broad experience across academic environments, public-health institutions, public-hospital research units, and contract research environments, contributing to study design, statistical analysis, questionnaire validation, database management, health economic evaluations, and scientific publications. At OXON, he provides advanced statistical and health economics expertise, ensuring scientific rigor and high-quality analytical outputs across projects, including studies involving safety data and real-world evidence generation.
Marta Mariño, BSc
Director of Pharmacovigilance
Marta has more than 30 years of experience in pharmacovigilance and drug safety, with extensive expertise across clinical development and post-marketing activities. At OXON Epidemiology, she leads the company’s Pharmacovigilance function, ensuring compliance with local and international regulatory requirements, internal procedures, and industry standards. She oversees pharmacovigilance quality management activities, supports inspection readiness, and acts as Local Contact Person for Pharmacovigilance (LCPPV).
Marta has particular expertise in the operational, quality and compliance aspects of safety in observational studies and patient registries and plays a key role in ensuring the quality and compliance of quantitative safety projects at OXON.
Javier Scott-Glendonwyn, BSc MSc
Director of Data Management
Javier holds a BSc in Pharmaceutical Sciences and a Master’s degree in Industrial Management. He is Director of Data Management at OXON, where he leads the coordination of data management activities and drives the design, development and evolution of OXON’s Data Management System, including the OXONeDC electronic data capture platform. He is also responsible for building and managing the team, processes, policies, structure and technology required to ensure the consistent delivery of high-quality data.
He brings over 25 years of experience in the pharmaceutical and technology sectors, with a long-standing focus on electronic data capture systems and their implementation. Across his career, he has worked in data management, software development coordination, client-facing project delivery and business development, including early-stage technology ventures later integrated into global CRO environments. This combination of technical, operational and strategic expertise allows him to support the delivery of robust and efficient data solutions at OXON.
Janine de Haan, BSc MSc
Director of Clinical Operations
Janine holds an MSc in Clinical Trial Management and has more than a decade of experience in clinical research and project operations. At OXON, she serves as Director of Clinical Operations, leading the Operations team and overseeing the delivery of global and European observational studies. She is responsible for project oversight, resource allocation, quality, compliance, and client satisfaction, while also supporting the effective coordination of cross-functional teams across complex international projects.
Her previous background across clinical research, late-phase trials, and operational roles in the medical device field has provided her with valuable experience in global study coordination, safety reporting, regulatory processes, site collaboration, and international stakeholder management.
At OXON, she brings solid operational leadership, a practical understanding of study delivery, and broad international project management experience, helping to ensure that complex studies are conducted efficiently and to a high standard of quality.
Bélène Podmore, BSc MSc PhD
Director of Epidemiology
Bélène is Director of Epidemiology at OXON and holds a PhD in Clinical Epidemiology from the London School of Hygiene & Tropical Medicine, where she also worked as a Research Fellow, and a Master of Public Health from Imperial College London.
As Director of Epidemiology, she leads the Epidemiology team at OXON, overseeing the design and delivery of epidemiological research across a wide range of real-world evidence study types. She brings extensive expertise in epidemiologic methods, large healthcare database analysis, and the generation of high-quality evidence to support both client objectives and scientific excellence.
Her background includes academic research in clinical epidemiology, extensive work with large national healthcare datasets, and experience assessing population healthcare needs across London and evaluating the impact of healthcare interventions and new models of care. This combination of academic rigor and applied experience enables her to bring both scientific depth and strategic insight to OXON’s epidemiology and real-world evidence projects.
Alliances and Partnerships
OXON has established a range of strategic partnerships to enhance its capabilities in various areas of research and analysis.
Our expertise is further boosted by renowned Consultants (close collaborators on retainers) for involvement in projects as necessary
STATISTICS EXPERT
Stuart Pocock, MA PhD, Professor of Medical Statistics at the London School of Hygiene & Tropical Medicine, is an eminent medical statistician, a frequent lecturer on a variety of clinical trials issues and co-author of over 600 articles in peer-reviewed journals, (100+ NEJM/Lancet, and STROBE guideline) mainly in trials and epidemiology. He has an extensive experience with EMA/FDA and data monitoring (including Covid DISCOVERY adaptive platform trial) and devised: ´Pocock Stopping Rule´, ´Win Ratio´ and new method for ‘Individualising Benefit Risk’. Awarded the Bradford Hill Medal in 2013 by the Royal Statistical Society, Stuart has provided OXON with advice and validation of several complex analyses over the last 10 years.
AGREEMENTS AND COLLABORATIONS
– Agreement with two qualitative research companies to support cognitive testing and validation of questionnaires and additional risk minimisation materials in countries where they are developed by OXON.
– Close relationships with leading pharmaco-epidemiologists across key EU and Scandinavian countries to conduct multi-country database studies, including those related to pregnancy outcomes.
– Alliance with a major Health Maintenance Organization (HMO) in the USA to conduct database analyses in the US.
– Collaboration with a global health economics (HE) group to jointly perform economic modelling and develop Health Technology Assessment (HTA) dossiers.